Bertolini E - Search Results

1

Ursodeoxycholic acid for chronic liver diseases.

Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M. Podda M, et al. Among authors: bertolini e. J Clin Gastroenterol. 1988;10 Suppl 2:S25-31. J Clin Gastroenterol. 1988. PMID: 3062082 Review.

2

Hepatitis C virus testing in primary biliary cirrhosis.

Bertolini E, Battezzati PM, Zermiani P, Bruno S, Moroni GA, Marelli F, Villa E, Manenti F, Zuin M, Crosignani A, et al. Bertolini E, et al. J Hepatol. 1992 May;15(1-2):207-10. doi: 10.1016/0168-8278(92)90037-p. J Hepatol. 1992. PMID: 1324271

3

Antibodies to hepatitis C virus in primary biliary cirrhosis.

Bertolini E, Marelli F, Zermiani P, Battezzati PM, Zuin M, Moroni GA, Podda M. Bertolini E, et al. Arch Virol Suppl. 1992;4:205-9. doi: 10.1007/978-3-7091-5633-9_43. Arch Virol Suppl. 1992. PMID: 1333323

4

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.

Crosignani A, Battezzati PM, Setchell KD, Camisasca M, Bertolini E, Roda A, Zuin M, Podda M. Crosignani A, et al. Among authors: bertolini e. Hepatology. 1991 Feb;13(2):339-44. Hepatology. 1991. PMID: 1671665 Clinical Trial.

5

Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis.

Bertolini E, Zermiani P, Battezzati PM, Bruno S, Villa E, Manenti F, Marelli F, Moroni GA, Zuin M, Podda M. Bertolini E, et al. Lancet. 1991 Mar 16;337(8742):675-6. doi: 10.1016/0140-6736(91)92491-j. Lancet. 1991. PMID: 1672013 No abstract available.

6

Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.

Zuin M, Petroni ML, Grandinetti G, Crosignani A, Bertolini E, Battezzati PM, Podda M. Zuin M, et al. Among authors: bertolini e. Scand J Gastroenterol. 1991 Mar;26(3):257-62. doi: 10.3109/00365529109025039. Scand J Gastroenterol. 1991. PMID: 1853147 Clinical Trial.

7

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KD. Crosignani A, et al. Among authors: bertolini e. Hepatology. 1991 Dec;14(6):1000-7. Hepatology. 1991. PMID: 1959845

8

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.

Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Crosignani A, et al. Among authors: bertolini e. Hepatology. 1991 Jun;13(6):1076-83. Hepatology. 1991. PMID: 2050325

9

Effect of different doses of ursodeoxycholic acid in chronic liver disease.

Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M. Podda M, et al. Among authors: bertolini e. Dig Dis Sci. 1989 Dec;34(12 Suppl):59S-65S. doi: 10.1007/BF01536665. Dig Dis Sci. 1989. PMID: 2598769 Clinical Trial.

10

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.

Colombo C, Bertolini E, Assaisso ML, Bettinardi N, Giunta A, Podda M. Colombo C, et al. Among authors: bertolini e. Acta Paediatr. 1993 Jun-Jul;82(6-7):562-5. doi: 10.1111/j.1651-2227.1993.tb12754.x. Acta Paediatr. 1993. PMID: 8338990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters